Status:
RECRUITING
Baclofen for Children With Rumination Syndrome
Lead Sponsor:
Nationwide Children's Hospital
Conditions:
Rumination Syndrome
Eligibility:
All Genders
4-18 years
Phase:
PHASE3
Brief Summary
The goal of this clinical trial is to learn about baclofen in pediatric patients with rumination syndrome. The main question it aims to answer is whether baclofen is effective in treating children wit...
Detailed Description
Rumination syndrome is a functional gastrointestinal disorder characterized by effortless, repetitive regurgitation of recently ingested meal. The objective of this study is to evaluate the efficacy o...
Eligibility Criteria
Inclusion
- Children 4-18 years of age who meets Rome IV diagnostic criteria for rumination syndrome and are see at NCH GI clinic
Exclusion
- Patients who have contraindications to baclofen due to medical history and/or current medications
- Patients who are non- English speaking
- Patients who are pregnant
Key Trial Info
Start Date :
January 31 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05975684
Start Date
January 31 2023
End Date
July 1 2024
Last Update
July 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 73205